Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-25

Clinical Trial Update: Gestational Sulfadoxine-pyrimethamine and Azithromycin Treatment to Prevent Preterm Birth [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating gestational sulfadoxine-pyrimethamine and azithromycin to prevent preterm birth; the study is active but not currently recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Azithromycin (azithromycin)
  • Sulfadoxine-pyrimethamine (sulfadoxine-pyrimethamine)

Snippet

Sponsor: Tampere University | Conditions: Malaria, Sexually Transmitted Diseases | Phase 3 | Status: ACTIVE_NOT_RECRUITING